Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Glioblastoma 8Neoplasms 4Endometrial Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Non-alcoholic Fatty Liver Disease 1Multiple Myeloma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Kidney Neoplasms 1Ketogen-based Therapeutic Diet 1Intermittent Fasting 1Head and Neck Neoplasms 1Growth Hormone-Secreting Pituitary Adenoma 1Glioma 1Fatty Liver 1Estrogen Receptor-positive Breast Cancer 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 326Carboplatin 318Bevacizumab 167Gemcitabine 106pembrolizumab 101liposomal doxorubicin 100Cyclophosphamide 96Topotecan 93Cisplatin 89olaparib 86niraparib 60Docetaxel 56Taxes 52Doxorubicin 50Drug Therapy 42fludarabine 40Filgrastim 39Nivolumab 37Etoposide 32Specimen Handling 31Magnetic Resonance Spectroscopy 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Albumin-Bound Paclitaxel 25durvalumab 24aldesleukin 24Hyperthermic Intraperitoneal Chemotherapy 24Oxaliplatin 23Biopsy 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ovarian Neoplasms × Diet, Ketogenic × Clear all
NCT03171506 2017-08-10

Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification

University of Alabama at Birmingham

Phase NA Completed
57 enrolled
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡